1. Home
  2. PROV vs SLDB Comparison

PROV vs SLDB Comparison

Compare PROV & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

HOLD

Current Price

$17.06

Market Cap

103.7M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$7.15

Market Cap

759.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
SLDB
Founded
1956
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.7M
759.8M
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
PROV
SLDB
Price
$17.06
$7.15
Analyst Decision
Hold
Strong Buy
Analyst Count
2
11
Target Price
$16.25
$16.36
AVG Volume (30 Days)
6.2K
965.3K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
34.97
EPS
0.68
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
$4.14
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
$25.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.85
$2.61
52 Week High
$17.42
$8.87

Technical Indicators

Market Signals
Indicator
PROV
SLDB
Relative Strength Index (RSI) 56.17 45.21
Support Level $16.93 $6.58
Resistance Level $17.38 $7.33
Average True Range (ATR) 0.21 0.45
MACD -0.04 -0.02
Stochastic Oscillator 31.48 34.10

Price Performance

Historical Comparison
PROV
SLDB

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: